Gabri van der Pluijm

3PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 17, 2021
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models.

Arjanneke F van de Merbel, Geertje van der Horst, Maaike H van der Mark

|Nov 11, 2020
Patient-derived tumour models for personalized therapeutics in urological cancers.

Arjanneke F van de Merbel, Geertje van der Horst, Gabri van der Pluijm

Pageof 1